MedPath

Impact of Early Enteral vs. Parenteral Nutrition on Preservation of Gut Mucosa Integrity in Patients Requiring Mechanical Ventilation and Catecholamine

Not Applicable
Terminated
Conditions
Shock
Acute Respiratory Failure
Interventions
Other: Enteral Nutrition
Other: Parenteral nutrition
Registration Number
NCT03852940
Lead Sponsor
Centre Hospitalier Departemental Vendee
Brief Summary

To demonstrate that a strategy involving early first-line enteral nutrition is associated with improved preservation of gut mucosa integrity, as assessed based on the plasma citrulline level at H72, compared to a strategy involving early first-line parenteral nutrition

Detailed Description

Published data suggest that enteral nutrition may be associated with improved preservation of the gut lymphoid tissues and gut immune function, as well as with decreased gut mucosa permeability, thereby diminishing the risk of organ failure. Citrulline is an amino acid produced from glutamine by small-bowel enterocytes. Plasma citrulline levels reflect functional enterocyte mass. Intestinal fatty acid-binding protein (I-FABP, also known as FABP2) is a small protein found in the cytosol of small-bowel enterocytes. Plasma I-FABP is normally undetectable and, when elevated, constitutes a reliable marker for enterocyte damage. The hypothesis underlying this ancillary study is that first-line enteral nutrition is associated with improved gut mucosa integrity and function compared to parenteral nutrition.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
169
Inclusion Criteria
  • Invasive mechanical ventilation expected to be required more than 48 hours
  • Nutrition started within 24 hours after initiation of endotracheal mechanical ventilation
  • Treatment with vasoactive drug administered via a central venous catheter
  • Age over 18 years
  • Signed information
Exclusion Criteria
  • Abdominal surgery within 1 month before inclusion
  • History of esophageal, gastric, duodenal or pancreatic surgery
  • Bleeding from the esophagus, stomach or bowel
  • enteral nutrition via gastrostomy or jejunostomy
  • pregnancy
  • Treatment-limitation decisions
  • Current inclusion in a trial on comparison between enteral and parenteral nutrition

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Enteral nutritionEnteral NutritionPatients will receive nutrition only via the enteral route during the firs week of invasive mechanical ventilation.
Parenteral nutritionParenteral nutritionPatients will receive parenteral nutrition during the first week of mechanical ventilation. After Day 3, the parenteral route may be switched to the enteral route if shock resolve (vasoactive drug stopped since 24 hours and serum lactate level \< 2 mmol/l). After Day 7, all patients will be fed via the enteral route.
Primary Outcome Measures
NameTimeMethod
Plasma citrulline level72 hours
Secondary Outcome Measures
NameTimeMethod
SOFA scorefirst week
plasma levels of citrullineDay 0, Day 3, Day 8
I-FABPDay 0, Day 3, Day 8
proportion of patients whose plasma citrulline is ≤10 μL/LDay 0, Day 3, Day 8
mean plasma I-FABPDay 0, Day 3, Day 8
proportion of patients with at least one episode of bacteremiauntil discharge from ICU (average: 10 days)
proportion of patients whose plasma I-FABP is ≥100 pg/mLDay 0, Day 3, Day 8
mean plasma citrullineDay 0, Day 3, Day 8
proportion of patients with at least one episode of gastrointestinal intoleranceuntil discharge from ICU (average: 10 days)
proportion of patients with at least one episode of diarrheauntil discharge from ICU (average: 10 days)

Trial Locations

Locations (6)

CH de Dieppe

🇫🇷

Dieppe, France

CHU Saint Louis

🇫🇷

Paris, France

CHU Tours

🇫🇷

Tours, France

CHU Amiens

🇫🇷

Amiens, France

CHU Lille

🇫🇷

Lille, France

Centre hospitalier d'Annecy

🇫🇷

Annecy, France

© Copyright 2025. All Rights Reserved by MedPath